Spero Therapeutics, Inc. (SPRO)

Spero Therapeutics Stock Forecast

SPRO's stock price has decreased by -59.65% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Spero Therapeutics stock have an average target of 5.00, which predicts an increase of 620.46% from the current stock price of 0.69.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$5.00	$5.00	$5.00	$5.00
Change	+620.46%	+620.46%	+620.46%	+620.46%

* Price targets were last updated on Jan 30, 2025.

Analyst Ratings

The average analyst rating for Spero Therapeutics stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	2	1	1	1	1	1
Buy	1	1	1	1	1	1
Hold	0	1	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	4	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $5	Strong Buy	Reiterates	$5	+620.46%	Jan 30, 2025
Josh Schimmer Evercore ISI Group	Evercore ISI Group	Buy → Hold Downgrades $5	Buy → Hold	Downgrades	$5	+620.46%	Dec 20, 2024
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $5	Strong Buy	Reiterates	$5	+620.46%	Dec 2, 2024
Ritu Baral TD Cowen	TD Cowen	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Nov 18, 2024
Louise Chen Cantor Fitzgerald	Cantor Fitzgerald	Buy Reiterates n/a	Buy	Reiterates	n/a	n/a	Nov 15, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

30.60M

Decreased by -36.22%

from 47.98M

Revenue Next Year

1.33M

Decreased by -95.67%

from 30.60M

EPS This Year

-0.58

from -1.27

EPS Next Year

-0.52

from -0.58

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	9.33M	18.26M	53.51M	103.78M	47.98M	30.60M	1.33M	36.31M
Revenue Growth	-48.59%	95.67%	193.10%	93.95%	-53.77%	-36.22%	-95.67%	2,638.46%
EPS	-3.52	-2.91	-1.23	0.43	-1.27	-0.58	-0.52	-0.02
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	5	3	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	63.0M	1.4M	40.6M
Avg	30.6M	1.3M	36.3M
Low	n/a	1.3M	31.9M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	31.3%	-95.5%	2,964.5%
Avg	-36.2%	-95.7%	2,638.5%
Low	-	-95.8%	2,302.0%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-0.13	-0.54	0.18
Avg	-0.58	-0.52	-0.02
Low	-0.82	-0.50	-0.20

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.